These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31541103)

  • 1. Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes.
    van Meer BJ; Krotenberg A; Sala L; Davis RP; Eschenhagen T; Denning C; Tertoolen LGJ; Mummery CL
    Nat Commun; 2019 Sep; 10(1):4325. PubMed ID: 31541103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Voltage Sensitive Dye di-4-ANEPPS and Video-Based Contractility Measurements to Assess Drug Effects on Excitation-Contraction Coupling in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP; Zamora V; Burton FL; Smith GL
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):280-290. PubMed ID: 33109927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Optical Imaging of Action Potentials and Calcium Transients in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Yang H; Yang Y; Lu Z; Zhang JZ
    Curr Protoc; 2024 Jul; 4(7):e1101. PubMed ID: 38980221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Investigation of Action Potential and Calcium Handling Maturation of hiPSC-Cardiomyocytes on Biomimetic Substrates.
    Pioner JM; Santini L; Palandri C; Martella D; Lupi F; Langione M; Querceto S; Grandinetti B; Balducci V; Benzoni P; Landi S; Barbuti A; Ferrarese Lupi F; Boarino L; Sartiani L; Tesi C; Mack DL; Regnier M; Cerbai E; Parmeggiani C; Poggesi C; Ferrantini C; Coppini R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.
    Bedut S; Seminatore-Nole C; Lamamy V; Caignard S; Boutin JA; Nosjean O; Stephan JP; Coge F
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H44-53. PubMed ID: 27199128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Parikh SS; Blackwell DJ; Gomez-Hurtado N; Frisk M; Wang L; Kim K; Dahl CP; Fiane A; Tønnessen T; Kryshtal DO; Louch WE; Knollmann BC
    Circ Res; 2017 Dec; 121(12):1323-1330. PubMed ID: 28974554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
    Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
    Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes.
    Zhang JZ; Zhao SR; Tu C; Pang P; Zhang M; Wu JC
    STAR Protoc; 2021 Dec; 2(4):100859. PubMed ID: 34746854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes.
    Okai Y; Matsune K; Yamanaka K; Matsui T; Pfeiffer Kaushik E; Harada K; Kohara H; Miyawaki A; Ozaki H; Wagoner M; Shinozawa T
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106893. PubMed ID: 32619502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.
    Lemme M; Braren I; Prondzynski M; Aksehirlioglu B; Ulmer BM; Schulze ML; Ismaili D; Meyer C; Hansen A; Christ T; Lemoine MD; Eschenhagen T
    Cardiovasc Res; 2020 Jul; 116(8):1487-1499. PubMed ID: 31598634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
    Zhang X; Guo L; Zeng H; White SL; Furniss M; Balasubramanian B; Lis E; Lagrutta A; Sannajust F; Zhao LL; Xi B; Wang X; Davis M; Abassi YA
    J Pharmacol Toxicol Methods; 2016; 81():201-16. PubMed ID: 27282640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes.
    Cai C; Huang J; Lin Y; Miao W; Chen P; Chen X; Wang J; Chen M
    Arch Toxicol; 2019 Apr; 93(4):1009-1020. PubMed ID: 30806761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.